BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Natera Presents Data at ESMO GI on its Tissue-Free Latitude™ MRD* Assay, Demonstrating Excellent Overall Performance in Colorectal Cancer

  July 8, 2025

   · 

  3 min read
• Press Releases

  Immix Biopharma Announces Accelerated NEXICART-2 Clinical Trial Progress in relapsed/refractory AL Amyloidosis

  July 8, 2025

   · 

  5 min read
• Press Releases

  Sirtex Medical’s SIR-Spheres® Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma

  July 8, 2025

   · 

  3 min read
• Press Releases

  Morphic Medical Announces CE Mark for RESET® Endoscopic Device Therapy

  July 8, 2025

   · 

  4 min read
• Press Releases

  Restore Medical LTD secures $23M to Advance Breakthrough Medical Device for Heart Failure Therapy

  July 8, 2025

   · 

  3 min read
• Press Releases

  OneOncology Appoints Dr. Michael Byrne as Medical Director for Cellular Therapy

  July 8, 2025

   · 

  3 min read
• Press Releases

  Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma

  July 8, 2025

   · 

  7 min read
• Press Releases

  MapLight Therapeutics Announces Initiation of Phase 2 Trial of Its Novel M1/M4 Muscarinic Agonist ML-007C-MA for the Treatment of Schizophrenia

  July 8, 2025

   · 

  3 min read
• Press Releases

  SELLAS Life Sciences Appoints Linghua Wang, MD, PhD, to Scientific Advisory Board

  July 8, 2025

   · 

  5 min read
• Press Releases

  Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)

  July 8, 2025

   · 

  8 min read